The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Tricky, I’m no longer invested but I’m still very interested in this share. I’m curious to know if I made the right decision in selling out at 2.55p. I’m curious as to how this pans out. I also feel I have a good idea about this share so could potentially make money here if things change for the better.
I agree Alf, in the last QnA, Huw said share price performance was really important to them. If it was that important then buy in, give more helpful info on when income from Stalicla is going to be received so investors know that funds are not going to run out.
One thing I can guarantee here is that Huw and the other board members will be laughing their behinds off seeing mugs investing here. I bet they go around saying “I bought a new car at the weekend, all courtesy of those mugs Trickymatters and DSFiat.
Have you also noticed how quiet K3VMC has been in recent months. He was giving it large that we were talking nonsense in saying this was looking like a bad investment. Kev, if you’re reading, I do need an apology from you.
Never astonishes me how naive some people are here. The drop was inevitable, you see it on every AIM share where there is a big rise and lots of volume being bought. The MMs take the share price exceptionally high because few people will sell believing it will go much further but lots of people keep buying at the sky high prices. The MMs then take it down quickly so that lots are still holding a profit but lots are holding a loss. MMs are trying to make money here too. You have to trade shares like this.
Usually this half year report doesn’t come until the first week in December, didn’t expect it to come this early.
I thought the report was encouraging as one of the biggest fears for some shareholders is a share placing next year if funds start running out. But the cash reserves are better than I expected. I expected about £3m left in cash by end of September. It looks hopeful that a share placing can be averted next year but it really would be helpful to the share price if EVG would bring clarity on when the payments are likely to be received.
I’m still not buying back in though. There may not be a lot of news coming in for the rest of the year now, the share price soon starts to fall again when no news for weeks on end.
I think you may have sold out a day too early Alf. The cash reserves are better than I expected but there is still a lack of clarity on when Stalicla payments are due.
Unfortunately everything takes forever here and although there is promising work being done how long before any more income streams arrive?
The West is destroying itself with woke liberal ideology. I have no idea who is behind it but they are turning America and Europe into one a huge mess and a complete disaster long term. You won’t see China or Russia allow this nonsense.
Anyone worth their salt knows how these shares work, same with OBD. The MMs take the share price way up to catch people buying in at really high prices and then drop the SP down sharpish so lots are holding at a loss. You have to take advantage of that and sell out when it’s clearly way too high and then buy back in once it levels out at the lower price.
You lot are rookie investors but we all have to learn.
Finally some news after two months but it’s the same old same old, the start of new studies, it will take god knows how long and brings no cash into the business. EVG needs cash and quickly.
Suthy, I can’t understand why they originally wrote $6m to be received by end of 2023 if it wasn’t set in stone. The wording now is not even confident they will receive the $5.5m by end of 2024, it is simply worded as “ Up to $5.5m in further milestones expected within 2024”. What exactly does that mean?
I do agree with flashgarden, EVG need to find a way to generate income to fund the company. Getting grants for clinical trials or partnerships with other pharmas is great but these things obviously take years before any money starts to roll in. How can any business run without money coming in?
*slight correction to the previous post. It is bet two £10 accas and get a free £10 acca bet. One per week.
Nice and interesting read Gewillia. They must have been good days, living like kings off the bookmakers must have felt good. There is a real excitement in doing that. Does the system still work in this current day? It’s always been a question I’ve been interested in - can the bookies be beaten?
I still maintain that Virginbet is the best sports betting platform (excluding the exchanges), the number of free bets they have on offer is ridiculous, they have a bet two £10 accas (4 selections with odds of 4.0 or higher) and get a free £10 bet. They have bet £10 on a single football match on Saturday and get a free £5 bet. Two Saturdays ago they had an offer of bet £10 on a particular race and get a free £10 bet if your horse loses (I won on a 12/1 shot that race). They also have free games you can win cash on. I wish now I had placed some big bets with Virginbet and Layed the same bet on the exchanges hoping to lose on the Virginbet so I’d appear to be a losing account.
I still bet on football daily but it’s not profitable long term, my main focus is pre race trading on the Betfair exchange. I’m studying pre race markets and trying to solve the puzzle, I’m hopeful.
It is as you say commonplace bookmakers closing profitable accounts. It is therefore surely a very lucrative operation if their customers are primarily losers.
Bobsson, that guidance changed in the full year results to: o Up to $5.5m in further milestones expected within 2024.
They shifted the goal posts from $5.5m will be received by end of 2023 to now being expected in 2024 but no time scale.
I think it all lies on the Stalicla deal and the money being received in time to avert a share placing. But the bizarre thing also is, Stalicla have a deal to pay EVG $160m in milestone payments if all goes to plan but EVG is currently only worth about £5m, surely Stalicla will just buy EVG out of the drug is effective for them meaning all this potential money is unlikely to ever be seen by EVG shareholders.
With regards to SFX-01 being a food supplement, wasn’t that what Juvenesense were planning SFX-01 for and they pulled the plug before it even materialised? No mention why. Was it not effective?
I don’t see any immediate sources of money likely from anywhere other than possibly Stalicla. Any deals EVG get like Stalicla was only £0.5m up front, such sums of money are simply not enough.
What shareholders need to know here is how the company will be funded over the next few years. And is it really worth investing if it’s going to be years before any real significant money will be realised?
Well since I wrote a week ago saying Virginbet was perhaps the best app, I’ve been effectively banned from using them. I was around £330 in profit since I opened the account in the summer. I got an email saying my account had been reviewed and I was no longer eligible to enter any promotions and my stakes will be restricted (to pennies) on any bets I place. Shocking! This is nothing short of a disgrace that they can turn away customers who maybe taking money off them but it’s ok if Virginbet take money off customers. I’m fuming at that. I hear this is a common practice from all online bookmakers including Paddypower and Skybet which seems immoral. Thank goodness for the Betfair exchange where the bookmaker does not care if the punter making a lot of money.
I agree with Cukkas that the quality of the apps are a major thing when betting. William Hill’s app is really very good, the best by a long way. Betfair sportsbook is so ordinary, the odds are really poor compared to other sites and it’s just boring and lame. I think they need to market and advertise more or have they given up with the UK scene. Have you seen many adverts lately for the Betfair exchange or paddy power?
Sounds a lot more promising over in America with fan duel. I too am interested in seeing the profits this coming year as in the past it was showing as a loss as the cost of attracting and retaining punters was high.
Well it’s been over two months since any news, there must be some news soon. But I think only news which involves money being received can help the share price here because the money is running out fast.
Oh and don’t get me started on their comments that they aren’t allowed to buy shares for legal reasons. They are treating shareholders as mugs. Just tell us “this is a turkey, it’s just not going to make any money for donkeys years”.
Depends what the news is. They need money desperately because it’s running out fast and they have no sources of income other than Stalicla payments but they are so vague, it was first said $6m would be received by the end of 2023 but that changed without any information given to as anticipated by the end of 2024’. So poor, I bought in believing the money would be received this year to keep the company funded a year longer.
Funny thing is, those who still believe in EVG believe everything EVG say and believe the money is coming.
We never even heard the real reason Juvenesense pulled out. It’s just really poor how they try to keep shareholders in the dark as if we don’t need to know this stuff.